Table 3

Estimated number of users per 10 000 population with an acute presentation of an NCD

CountryAdults with hypertensive urgencyAdults with hypertensive emergencyAdult with hypertensionAdults with severe hyperglycaemiaAdults with severe hypoglycaemiaChildren with severe hyperglycaemiaChildren with severe hypoglycaemiaAdults with acute MIAdults with acute strokeAdults with heart failureAdults with asthma attacksChildren with asthma attacksAdults with COPD exacerbation
Bangladesh11415411051116966825
Central African Republic93122871111513571019
Egypt11415317911161068827
Guinea93123077111312571019
Indonesia11415307811111368729
Iraq93124511611169571019
Jordan10414711831116968821
Lebanon13518591521116979635
Liberia93123078111311571018
Philippines10414266811111369964
Sierra Leone93123386111312571018
Syrian Arab Republic10414501301116967921
Turkey12416461191116979726
Ukraine145195614511233287447
  • Acute NCD presentations include acute coronary syndrome, acute stroke, acute heart failure, hypertensive urgency/emergency, acute severe hyperglycaemia or hypoglycaemia, COPD exacerbation, asthma exacerbation.

  • COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; NCD, non-communicable disease.